NantKwest is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer (NK) cells to treat cancer, infectious diseases, and inflammatory diseases. The Company's NK cell-based platform, with the capacity to grow active killer cells as a biological cancer therapy, has been designed to induce cell death against cancer or infected cells by three different modes of action: direct killing using activated NK cells (aNK) that release toxic granules directly into the cell through cell to cell contact; antibody-mediated killing using haNKs, which are NK cells engineered to incorporate a high-affinity receptor that binds to an administered antibody, enhancing the cancer cell killing effect of that antibody, and Target-activated killing using taNKs, which are NK cells engineered to incorporate chimeric antigen receptors (CARs) to target tumor-specific antigens found on the surface of cancer cells.

Employee Rating

2.4More
TypePublic
HQSan Diego, US
Founded2014
Size (employees)118 (est)+27%
Websitenantkwest.com
NantKwest was founded in 2014 and is headquartered in San Diego, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

NantKwest Office Locations

NantKwest has an office in San Diego
San Diego, US (HQ)
3530 John Hopkins Ct
Show all (1)
Report incorrect company information

NantKwest Financials and Metrics

NantKwest Revenue

NantKwest's revenue was reported to be $45 k in FY, 2017
USD

Revenue (Q2, 2018)

4.0k

Net income (Q2, 2018)

(27.7m)

EBIT (Q2, 2018)

(28.3m)

Market capitalization (14-Dec-2018)

107.0m

Closing stock price (14-Dec-2018)

1.4

Cash (30-Jun-2018)

16.1m
NantKwest's current market capitalization is $107 m.
Annual
USDFY, 2015FY, 2016FY, 2017

Revenue

236.0k44.0k45.0k

General and administrative expense

227.7m95.4m57.1m

R&D expense

11.4m29.2m42.0m

Operating expense total

239.1m124.5m99.2m
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

91.0k10.0k6.0k12.0k12.0k11.0k14.0k8.0k5.0k4.0k

General and administrative expense

82.4m38.9m26.7m28.6m24.4m16.2m14.1m13.4m14.3m13.6m

R&D expense

1.7m4.0m4.9m6.4m8.4m9.2m9.7m11.1m14.0m14.7m

Operating expense total

84.2m42.8m31.6m35.0m32.8m25.5m23.8m24.5m28.3m28.3m
Annual
USDFY, 2015FY, 2016FY, 2017

Cash

175.9m8.1m23.9m

Accounts Receivable

363.0m

Current Assets

297.5m205.1m132.5m

PP&E

5.5m18.9m76.7m
Quarterly
Annual
USDFY, 2015FY, 2016FY, 2017

Net Income

(236.9m)(120.8m)(96.4m)

Depreciation and Amortization

1.5m3.6m5.6m

Accounts Payable

627.0k888.0k150.0k

Cash From Operating Activities

(25.3m)(38.6m)(48.8m)
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

(117.4m)(160.1m)(30.6m)(64.7m)(96.6m)(24.5m)(48.0m)(71.9m)(27.5m)(55.3m)

Depreciation and Amortization

1.0m1.1m485.0k998.0k1.8m1.2m2.5m4.0m1.6m4.0m

Accounts Payable

2.0m3.8m(737.0k)84.0k321.0k725.0k(1.1m)1.5m117.0k1.9m

Cash From Operating Activities

(10.0m)(14.2m)(8.9m)(17.2m)(27.8m)(10.1m)(25.0m)(35.1m)(15.5m)(31.8m)
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

NantKwest Online and Social Media Presence

Embed Graph
Report incorrect company information

NantKwest News and Updates

Natural Killer Cells Market Prognosticated For A Ravishing Growth By 2026 Global Key Players NantKwest, NKT Therapeutics Inc, AvidBiotics, Glycostem, Sorrento Therapeutics, Inc., CellGenix GmbH, Lonza and R&D Systems, Inc.

#Summary: Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Posted via Industry Today. Follow us on Twitter…
Report incorrect company information

NantKwest Blogs

NantKwest to Participate at Citi 2018 Global Healthcare Conference

The post NantKwest to Participate at Citi 2018 Global Healthcare Conference appeared first on NantKwest.

NantKwest to Present Updated Preclinical Data at the 60th Annual Meeting of the American Society of Hematology

The post NantKwest to Present Updated Preclinical Data at the 60th Annual Meeting of the American Society of Hematology appeared first on NantKwest.

NantKwest to Participate at Upcoming Investment Conferences

The post NantKwest to Participate at Upcoming Investment Conferences appeared first on NantKwest.

NantKwest Announces Promising First in Human Clinical Results of 300 Doses Of CD16 Targeted, Off-The-Shelf Cryopreserved Natural Killer Cells (haNK) in a Novel Cancer Memory Vaccine Immunotherapy

NantKwest Announces Promising First in Human Clinical Results of 300 Doses Of CD16 Targeted, Off-The-Shelf Cryopreserved Natural Killer Cells (haNK) in a Novel Cancer Memory Vaccine Immunotherapy Content Import Wed, 11/07/2018 - 17:29 NantKwest Announces Promising First in Human Clinical R…

NantKwest Announces Promising First in Human Clinical Results of 300 Doses of CD16 Targeted, Off-the-Shelf Cryopreserved Natural Killer Cells (haNK) in a Novel Cancer Memory Vaccine Immunotherapy

The post NantKwest Announces Promising First in Human Clinical Results of 300 Doses of CD16 Targeted, Off-the-Shelf Cryopreserved Natural Killer Cells (haNK) in a Novel Cancer Memory Vaccine Immunotherapy appeared first on NantKwest.

Dr. Patrick Soon-Shiong Presents at Society for Immunotherapy of Cancer

The post Dr. Patrick Soon-Shiong Presents at Society for Immunotherapy of Cancer appeared first on NantKwest.
Show more

NantKwest Company Life and Culture

Report incorrect company information

NantKwest Frequently Asked Questions

  • When was NantKwest founded?

    NantKwest was founded in 2014.

  • How many employees does NantKwest have?

    NantKwest has 118 employees.

  • What is NantKwest revenue?

    Latest NantKwest annual revenue is $45 k.

  • What is NantKwest revenue per employee?

    Latest NantKwest revenue per employee is $381 .

  • Who are NantKwest competitors?

    Competitors of NantKwest include Heat Biologics, Cleveland BioLabs and Immune Design.

  • Where is NantKwest headquarters?

    NantKwest headquarters is located at 3530 John Hopkins Ct, San Diego.

  • Where are NantKwest offices?

    NantKwest has an office in San Diego.

  • How many offices does NantKwest have?

    NantKwest has 1 office.